XML 193 R83.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Payments - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Jul. 05, 2024
Dec. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based compensation arrangement by share-based payment award, terms of award     ten      
Precigen Stock Option Plan 2023 Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Options outstanding (in shares)   5,824,000 5,824,000      
Restricted stock units outstanding (in shares)   0 0      
Number of authorized awards (in shares)   18,418,137 18,418,137      
Number of additional shares authorized (in shares) 2,000,000          
Precigen Stock Option Plan 2013 Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Remaining shares available to grant (in shares)   0 0      
Options outstanding (in shares)   16,414,686 16,414,686      
Precigen Stock Option Plan 2019 Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Remaining shares available to grant (in shares)   2,448,058 2,448,058      
Options outstanding (in shares)   3,686,048 3,686,048      
Restricted stock units outstanding (in shares)   826,057 826,057      
Number of authorized awards (in shares)   12,000,000 12,000,000      
Precigen Stock Option Plans            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Options outstanding (in shares)   25,924,734 25,924,734 22,057,340 15,201,276 12,260,187
Restricted stock units outstanding (in shares)   4,004,057 4,004,057 961,534 697,815 468,481
Granted (in shares)     7,769,484 4,083,777 1,387,831  
Recognized over weighted-average period     2 years 6 months      
Unrecognized compensation costs related to unvested stock option awards   $ 10,135 $ 10,135      
Weighted average grant date fair value of options granted (in usd per share)     $ 1.12 $ 0.92 $ 1.65  
Aggregate intrinsic value of options exercised     $ 60 $ 0 $ 0  
Granted (in shares)     7,361,674 7,847,869 4,451,890  
Restricted stock units | Precigen Stock Option Plan 2023 Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Remaining shares available to grant (in shares)   7,043,377 7,043,377      
Restricted stock units | Precigen Stock Option Plan 2013 Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Restricted stock units outstanding (in shares)   0 0      
Restricted stock units | Precigen Stock Option Plans            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Recognized over weighted-average period     3 months 18 days      
Unrecognized compensation costs related to restricted stock unit awards   $ 292 $ 292      
Options | Precigen Stock Option Plans            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based compensation arrangement by share-based payment award, terms of award     ten-year      
Vesting period of equity grant     4 years      
Phantom Share Units (PSUs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting period of equity grant     6 months      
Phantom Share Units (PSUs) | Precigen Stock Option Plan 2023 Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted (in shares)     3,178,000      
Granted (in shares)     2,978,000      
Phantom Share Units (PSUs) | Precigen Stock Option Plan 2023 Plan | Share-Based Payment Arrangement, Tranche One            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based compensation arrangement by share-based payment award, installment percentage   50.00%        
Phantom Share Units (PSUs) | Precigen Stock Option Plan 2024 Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted (in shares)     200,000      
Phantom Share Units (PSUs) | Precigen Stock Option Plan 2024 Plan | Share-Based Payment Arrangement, Tranche Two            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting rights percentage   50.00%        
Phantom Share Units (PSUs) | Omnibus Incentive Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted (in shares)     3,178,000